SNSadako Nakamura

Sadako Nakamura

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sadako Nakamura has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    1,5-Anhydro-D-Mannitol Is a Potentially Low-Energy Carbohydrate: A Dual-Model Approach in Rats and a Randomized, Three-Way Crossover Trial in Humans

    by Kenichi Tanabe, Ikuma Tanaka, Hiromi Hayashi, Kazuhiro Yoshinaga, Sadako Nakamura

    Background/Objectives: We hypothesized that orally ingested 1,5-anhydro-D-mannitol (AM) would be absorbed from the gut but poorly metabolized, and it may have low fermentability by gut microbiota based on the breath hydrogen test. Methods: We used a dual-model approach in this study. In animal experiments, AM was administered orally to male Wistar rats. In a randomized, three-way crossover trial (UMIN000054040), 15 healthy young adults consumed a single 5 g dose of AM, mannose, or fructooligosaccharide (FOS). Primary outcome was breath hydrogen concentrations; secondary outcomes included plasma AM, blood glucose concentration, and urinary AM excretion. Results: After ingestion of 5 g AM in humans, the 14 h area under the curve for breath hydrogen excretion was markedly lower after AM than that after FOS ingestion (p < 0.05). Plasma AM peaked at 1 h, whereas blood glucose remained unchanged from baseline. Approximately 30% of ingested AM was excreted unchanged in urine within 24 h. Results of animal experiments were similar to those in humans. Fecal excretion in AM was confirmed to be minimal, accounting for ~1% of the administered dose within 24 h in rats. Conclusions: These findings indicate that AM is potentially a low-energy carbohydrate.

  • Open Access

    Metabolic fate of newly developed nondigestible oligosaccharide, maltobionic acid, in rats and humans

    by Kenichi Tanabe, Asuka Okuda, Fukami Ken, Natsumi Yamanaka, Sadako Nakamura, Tsuneyuki Oku

    Maltobionic acid (MA), formed by a gluconic acid and glucose linked by an α‐1,4 bond, may have the properties of a nondigestible oligosaccharide. The objective of this study was to elucidate the bioavailability of MA in rats and humans by observing digestion of MA by small intestinal enzymes, the fermentation of MA by gut microbiota, and the effect of adaptation following prolonged ingestion of MA. MA digestion was assessed using brush border membrane vesicles (BBMV) from rat small intestine. A within‐subject repeated measures design was used for ingestion experiments in 10 healthy female participants. After MA ingestion, postprandial plasma glucose and insulin levels, breath hydrogen excretion, and urinary MA were measured. The effect of adaptation following prolonged MA ingestion was investigated in rats. MA was minimally hydrolyzed by BBMV. Ingestion of 10 g of MA by healthy females did not elevate postprandial plasma glucose and insulin levels. Breath hydrogen and urinary MA were negligibly excreted over 8 hr following ingestion. Adaptation to prolonged MA ingestion produced no significant difference in exhaled hydrogen levels over 8 hr following administration compared with controls. MA is a new food material that is highly resistant to digestion and fermentation. It expresses the characteristics of a nondigestible oligosaccharide, including being low energy, improving the flavor of food and juice, and mineral solubilization.


  • Fatal Imperfection of Enzymatic-HPLC Quantitative Method for Non-Digestible Oligosaccharides and Its Proposed Solution Strategy Newly Quantitative Method for Non-Digestible Oligosaccharides

    by Kenichi Tanabe, Sadako Nakamura, Tsuneyuki Oku

    The enzymatic-HPLC quantitative method is widely used for the determination of non-digestible oligosaccharide. However, the results obtained from the method are inconsistent with some reports. In the present study, we clarified the reason that the existent enzymatic-HPLC method could not accurately measure the quantity of non-digestible oligosaccharide, and then we developed the improved enzymatic-HPLC method for accurate quantification of non-digestible oligosaccharide. When some digestible and non-digestible oligosaccharides were measured by the existent enzymatic-HPLC method, 67% of isomaltooligosaccharide (IMO) was recovered as intact form, and 91% of sucrose and 95% of lactose were recovered as intact form, respectively. This result is questionable because IMO, sucrose and lactose were clearly measured as non-digestible oligosaccharides in this method. However, IMO was readily hydrolyzed and the intact form was not detected by the improved enzymatic-HPLC method which pig small intestinal enzymes were added to the hydrolyzing process in the existent enzymatic-HPLC method. Also, sucrose and lactose were completely hydrolyzed and the intact form were not recovered. The recovery rates of intact fructooligosaccharide (FOS) and resistant maltodextrin (RMD), which are not digested by small intestinal disaccharidase, were 92.1% and 78.8%, respectively. The contradiction appears to demonstrate that thermostable α-amylase and amyloglucosidase may not be able to hydrolyze the low molecular weight oligosaccharides, although they can hydrolyze spontaneously high molecular polysaccharides. In conclusion, the present study strongly suggests that the existent enzymatic-HPLC quantitative method cannot accurately measure non-digestible oligosaccharides, and that the improved enzymatic-HPLC method is suitable for the quantity of oligosaccharides.


  • Effects of ketamine on formalin‐induced activity in the spinal dorsal horn of spinal cord‐transected cats: differences in response to intravenous ketamine administered before and after formalin

    by H. Nagasaka, S. Nakamura, Y. Mizumoto, I. Sato

    Background: Although formalin has been widely used as an algesic substance in rodent studies, the unique biphasic effect seen in rats is not present in humans. Humans, like cats, have a monophasic behavioral response to formalin injection. Electrophysiologically, spinal dorsal horn neurons in cats also have what could be considered a monophasic response after the initial burst of activity following formalin injection. Although several studies of the effects of ketamine on formalin responses have been carried out in rodents, we are unaware of similar studies in cats. We hypothesize that such species differences may explain observed differences in preemptive analgesic effects. Therefore, we examined the effects of ketamine on activity of spinal wide dynamic range (WDR) neurons evoked by formalin injection in cats. Methods: We investigated in cats the effect of ketamine on the activity of WDR neurons in the spinal dorsal horn that was evoked by formalin. In addition, we studied the effects of pre‐ and post‐administration of ketamine on the maintained phase of the formalin response. Each dose was a subanesthetic, anesthetic or high anesthetic dose (3.0 mg · kg−1, 10 mg · kg−1, and 30 mg · kg−1). Results: Intravenously administered ketamine produced a dose‐dependent depression of evoked activity that was significantly greater when the drug was administered before formalin. Conclusions: In spite of the species differences in responses to formalin, there still appears to be a clear preemptive effect of ketamine in the cat. Species differences may not explain apparent differences between human and animal preemptive analgesia.